No doubt 2025 will usher in many more advances in CRISPR therapies, thanks to the FDA’s new Platform Technology Designation ...

There are numerous potential uses for the CRISPR-Cas gene scissors, ranging from antiviral treatments and diagnostics to the ...

The CRISPR-Cas gene scissors offer a wide range of potential applications, from the treatment of genetic diseases to ...

“‘DuTracer’为单细胞水平的谱系追踪设立了新标准。”论文通讯作者彭广敦表示，该技术通过巧妙结合两种基因编辑工具CRISPR-Cas9和Cas12a，显著提升了细胞谱系追踪的精度和深度，为解析胚胎发育、器官再生及疾病机制提供了全新工具。

CRISPR Therapeutics already has financial backing from Celgene and in October announced a discovery alliance with Vertex in cystic fibrosis. Novartis has a stake in rivals Intellia Therapeutics ...

CRISPR technology has radically transformed genetic research, and at the forefront of this transformation is CRISPR screening ...

Complementary discoveries have the potential to enhance treatment options for antibiotic-resistant infections. Researchers at the University of Illinois have made complementary discoveries that enhanc ...

The pharmaceutical landscape is undergoing a dramatic transformation. New modalities are reshaping what's possible in drug development, from monoclonal antibodies to RNA therapies, from small ...

The Food and Drug Administration approval in December 2023 of the first CRISPR therapeutic, Casgevy to treat sickle cell, came 11 years after the discovery of the revolutionary gene-editing technology ...